Determinants of endothelial function in asymptomatic subjects with and without the metabolic syndrome

Atherosclerosis

Volumn 197, Issue 1, 2008, Pages 375-382

  Melikian, Narbeh ^a   Chowienczyk, Philip ^a   MacCarthy, Philip A ^b   Williams, Ian L ^b   Wheatcroft, Stephen B ^c   Sherwood, Roy ^b   Gale, Christopher ^c   Shah, Ajay M ^a   Kearney, Mark T ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Endothelial function; Metabolic syndrome; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; INFLAMMATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADULT; BIOLOGICAL MARKERS; BRACHIAL ARTERY; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MASS SCREENING; METABOLIC SYNDROME X; PREDICTIVE VALUE OF TESTS; ROC CURVE; SENSITIVITY AND SPECIFICITY; VASCULITIS;

EID: 39549097927     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.06.009     Document Type: Article

References (30)

1. Landmesser U., Hornig B., and Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 109 Suppl. II (2004) II-27-II-33
2. Trepels T., Zeiher A.M., and Fichtlscherer S. The endothelium and inflammation. Endothelium 13 (2006) 423-429
3. Celermajer D.S., Sorenson K.E., Bull C., Robinson J., and Deanfield J.E. Endothelial-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24 (1994) 1468-1474
4. Melikian N., Wheatcroft S.B., Okechukwu O.S., et al. Asymmetric dimethylarginine and reduced nitrix oxide bioavailability in young Black African men. Hypertension 49 (2007) 873-877
5. Murphy C., Kanaganayagam G.S., Jiang B., et al. Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. Arterioscler Thromb Vasc Biol 27 (2007) 936-942
6. Steinberg H.O., Chaker H., Leaming R., et al. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97 (1996) 2601-2610
7. Williams I.L., Chowienczyk P.J., Wheatcroft S.B., et al. Endothelial function and weight loss in obese humans. Obes Surg 15 (2005) 1055-1560
8. Hsueh W.A., and Quinones M.J. Role of endothelial dysfunction in insulin resistance. J Am Coll Cardiol 92 Suppl. 10 (2003) 10J-17J
9. Stroes E.S., Koomans H.A., de Bruin T.W., and Rabelink T.J. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 346 (1995) 467-471
10. Mancini G.B., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition in patients with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND (trial on reversing endothelial dysfunction) study. Circulation 94 (1996) 258-265
11. Blaschke F., Caglayan E., and Hsueh W.A. Peroxisome proliferator-activated receptor gamma agonists: their role as vasoprotective agents in diabetes. Endocrinol Metab Clin North Am 35 (2006) 561-574
12. Al Suwaidi J., Hamasaki S., Higano S.T., et al. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 (2000) 948-954
13. Schachinger V., Britten M.B., and Zeiher A.M. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101 (2000) 1899-1906
14. Halcox J.P.J., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 (2002) 653-658
15. Reilly M.P., and Rader D.J. The metabolic syndrome: more than the sum of its parts? Circulation 108 (2003) 1546-1551
16. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
17. Lohman T., Roche A., and Martorel R. Standardisation of anthropomorphic measurements. The airlie (VA) consensus conference. Champaign III (1988) 39-80
18. Hotamisligil G.S., Arber P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95 (1995) 2409-2415
19. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
20. Corretti M.C., Anderson T.J., Benjamin E.J., et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 (2002) 257-265
21. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
22. Frohlich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome. Diabetes Care 23 (2000) 1835-1839
23. Festa A., D'Agostino R., Howard G., et al. Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
24. Dell'Omo G., Penno G., Pucci L., et al. Abnormal capillary permeability and endothelial dysfunction in hypertension with comorbid metabolic syndrome. Atherosclerosis 172 (2004) 383-389
25. Lteif A.A., Han K., and Mather K.J. Obesity, insulin resistance, and the metabolic syndrome - determinants of endothelial dysfunction in whites and blacks. Circulation 112 (2005) 32-38
26. Wendelhag I., Fagerberg B., Hulthe J., Bokemark L., and Wikstrand J. Endothelium-dependent flow-mediated vasodilatation, insulin resistance and the metabolic syndrome in 60-year-old men. J Intern Med 252 (2002) 305-313
27. Clapp B.R., Hirschfield G.M., Storry C., et al. Inflammation and endothelial function - Direct vascular effects of human C-reactive protein on nitric oxide bioavailability. Circulation 111 (2005) 1530-1536
28. Farouque H.M.O., and Meredith I.T. The assessment of endothelial function in humans. Coron Artery Dis 12 (2001) 445-454
29. Momin A.U., Melikian N., Shah A.M., et al. Leptin is an endothelium-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. Eur Heart J 27 (2006) 2294-2299
30. Chambers J.C., and Kooner J.S. Homocysteine-an innocent bystander in vascular disease?. Eur Heart J 22 (2001) 717-719